Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Managing the Growing Epidemic of HF: The Potential Role of Shunts

CME

Managing the Growing Epidemic of HF: The Potential Role of Shunts

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty & Chordal Repair

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair TCT 2022

TAVR and Imaging Modalities: Impact on Clinical Practice and Decision Making

CME

TAVR and Imaging Modalities: Impact on Clinical Practice and Decision Making

TAVR in Expanded Patient Populations: Exploring the Next Frontier

CME

TAVR in Expanded Patient Populations: Exploring the Next Frontier

Low-Risk Patients: The Changing Face of TAVR

CME

Low-Risk Patients: The Changing Face of TAVR

Updates on TAVR in Low-Risk Patients

CME

Updates on TAVR in Low-Risk Patients

TAVR in 2019: Appropriate Metrics for Success

CME

TAVR in 2019: Appropriate Metrics for Success

CME

Recent TAVR Updates and Upcoming Studies at ACC 2016

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Everyday Antiplatelet Decisions: Making the Right Choices

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

CME

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

CME

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

CME

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

Expanded TAVR Indications: Post TCT 2016

CME

Expanded TAVR Indications: Post TCT 2016

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Key Design Criteria For True Next Generation DES

CME

Key Design Criteria For True Next Generation DES

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.